Gene Mack profile page

Gene Mack serves as chief executive officer and president of Gain Therapeutics. He joined the Company in April 2024 and brings 25 years of experience in the life sciences sector, spanning clinical research, financing and capital markets, investing, corporate strategy and business development. Prior to joining Gain, Gene Mack served as chief financial officer (CFO) at Imcyse SA (2021–2023), a privately held biotech company. Before that, he was CFO at OncoC4, which spun out of Merck & Co.’s $475 million acquisition of OncoImmune, where he had also been CFO. Earlier in his career, Gene held CFO roles at several development- and commercial-stage biopharma companies, raising over $350 million through IPOs and other equity financings. Before moving into operations, he was a senior publishing analyst covering biotechnology and life sciences at Gruntal & Co., Lazard, Mizuho and HSBC. He earned both his BS in biochemistry and his MBA in finance from Fordham University.